6,12-Dibromochrysene

We are 6,12-Dibromochrysene CAS:131222-99-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6,12-Dibromochrysene
CAS.NO:131222-99-6
Synonyms:Dibromochrysene
6,12-bis(bromanyl)chrysene
Molecular Formula:C18H10Br2
Molecular Weight:386.08000
 
Physical and Chemical Properties:
Density:1.722
Boiling point:526.8ºC
Flash point:315.3ºC
Index of Refraction:1.792
 
Specification:
Appearance:White solid
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

6,12-Dibromochrysene


Related News: The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.chlorodimethylvinylsilane The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.3- (Cianometil) Piridina CAS:6443-85-2 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.N-bencil-1- (4-metoxifenil) propan-2-amina CAS:43229-65-8 Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.

Related Products
Product Name
9-(2-Bromophenyl)-9H-carbazole View Details
6-bromoisoquinolin-3-amine Cas:891785-28-7 View Details
4-Fluorobenzoic Acid Cas:456-22-4 View Details
15-28-Somatostatin-28 Cas:38916-34-6 manufacturer Cetyl palmitate Cas:540-10-3 manufacturer 4-Tolylboronic Acid Cas:5720-05-8 manufacturer Laminin-1 peptide manufacturer Pyrazine, 2-propyl Cas:18138-03-9 manufacturer